153 related articles for article (PubMed ID: 31885639)
1. Yu Ping Feng San Exert Anti-Angiogenesis Effects through the Inhibition of TSLP-STAT3 Signaling Pathways in Hepatocellular Carcinoma.
Yuan Q; Yao F; Zhou L; Liang G; Song X; Jiang G; Zhou M; Zhang L
Evid Based Complement Alternat Med; 2019; 2019():1947156. PubMed ID: 31885639
[TBL] [Abstract][Full Text] [Related]
2. Yu-Ping-Feng-San ameliorates recurrent allergic inflammation of atopic dermatitis by repairing tight junction defects of the epithelial barrier.
Zheng J; Wang X; Tao Y; Wang Y; Yu X; Liu H; Ji L; Bao K; Wang C; Jia Z; Hong M
Phytomedicine; 2019 Feb; 54():214-223. PubMed ID: 30668371
[TBL] [Abstract][Full Text] [Related]
3. Chinese medicine Yu-Ping-Feng-San attenuates allergic inflammation by regulating epithelial derived pro-allergic cytokines.
Wang XT; Liu HL; Yu X; Wang C; Gui LL; Wang XY; Hua YQ; Zheng J; Hong M
Chin J Nat Med; 2019 Jul; 17(7):525-534. PubMed ID: 31514984
[TBL] [Abstract][Full Text] [Related]
4. Screening active components from Yu-ping-feng-san for regulating initiative key factors in allergic sensitization.
Shen D; Xie X; Zhu Z; Yu X; Liu H; Wang H; Fan H; Wang D; Jiang G; Hong M
PLoS One; 2014; 9(9):e107279. PubMed ID: 25198676
[TBL] [Abstract][Full Text] [Related]
5. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS
Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D
J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of Yu-Ping-Feng-San
Yang ZS; Yan JY; Han NP; Zhou W; Cheng Y; Zhang XM; Li N; Yuan JL
Iran J Basic Med Sci; 2016 Sep; 19(9):993-1002. PubMed ID: 27803787
[TBL] [Abstract][Full Text] [Related]
7. The Mechanisms of Yu Ping Feng San in Tracking the Cisplatin-Resistance by Regulating ATP-Binding Cassette Transporter and Glutathione S-Transferase in Lung Cancer Cells.
Du Y; Zheng Y; Yu CX; Zhong L; Li Y; Wu B; Hu W; Zhu EW; Xie VW; Xu Q; Zhan X; Huang Y; Zeng L; Zhang Z; Liu X; Yin J; Zha G; Chan K; Tsim KWK
Front Pharmacol; 2021; 12():678126. PubMed ID: 34135758
[TBL] [Abstract][Full Text] [Related]
8. Yu Ping Feng San, an Ancient Chinese Herbal Decoction, Induces Gene Expression of Anti-viral Proteins and Inhibits Neuraminidase Activity.
Du CY; Zheng KY; Bi CW; Dong TT; Lin H; Tsim KW
Phytother Res; 2015 May; 29(5):656-61. PubMed ID: 25586308
[TBL] [Abstract][Full Text] [Related]
9. A Chinese Prescription Yu-Ping-Feng-San Administered in Remission Restores Bronchial Epithelial Barrier to Inhibit House Dust Mite-Induced Asthma Recurrence.
Bao K; Yuan W; Zhou Y; Chen Y; Yu X; Wang X; Jia Z; Yu X; Wang X; Yao L; Wang S; Xu Y; Zhang Y; Zheng J; Hong M
Front Pharmacol; 2019; 10():1698. PubMed ID: 32076408
[TBL] [Abstract][Full Text] [Related]
10. Yu Ping Feng San, an ancient Chinese herbal decoction, regulates the expression of inducible nitric oxide synthase and cyclooxygenase-2 and the activity of intestinal alkaline phosphatase in cultures.
Du CY; Choi RC; Dong TT; Lau DT; Tsim KW
PLoS One; 2014; 9(6):e100382. PubMed ID: 24967898
[TBL] [Abstract][Full Text] [Related]
11. The WT1/MVP-Mediated Stabilization on mTOR/AKT Axis Enhances the Effects of Cisplatin in Non-small Cell Lung Cancer by a Reformulated Yu Ping Feng San Herbal Preparation.
Lou JS; Xia YT; Wang HY; Kong XP; Yao P; Dong TTX; Zhou ZY; Tsim KWK
Front Pharmacol; 2018; 9():853. PubMed ID: 30131696
[TBL] [Abstract][Full Text] [Related]
12. Yu Ping Feng San, an ancient Chinese herbal decoction containing Astragali Radix, Atractylodis Macrocephalae Rhizoma and Saposhnikoviae Radix, regulates the release of cytokines in murine macrophages.
Du CY; Choi RC; Zheng KY; Dong TT; Lau DT; Tsim KW
PLoS One; 2013; 8(11):e78622. PubMed ID: 24244327
[TBL] [Abstract][Full Text] [Related]
13. Potential effectiveness of Chinese herbal medicine Yu ping feng san for adult allergic rhinitis: a systematic review and meta-analysis of randomized controlled trials.
Luo Q; Zhang CS; Yang L; Zhang AL; Guo X; Xue CC; Lu C
BMC Complement Altern Med; 2017 Nov; 17(1):485. PubMed ID: 29110710
[TBL] [Abstract][Full Text] [Related]
14. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
[TBL] [Abstract][Full Text] [Related]
15. Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth.
Yang H; Wang J; Fan JH; Zhang YQ; Zhao JX; Dai XJ; Liu Q; Shen YJ; Liu C; Sun WD; Sun Y
Toxicol Appl Pharmacol; 2017 Jan; 315():90-101. PubMed ID: 27986624
[TBL] [Abstract][Full Text] [Related]
16. Screening of immunomodulatory components in Yu-ping-feng-san using splenocyte binding and HPLC.
Hong M; Wang XZ; Wang L; Hua YQ; Wen HM; Duan JA
J Pharm Biomed Anal; 2011 Jan; 54(1):87-93. PubMed ID: 20828965
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells.
Carbajo-Pescador S; Ordoñez R; Benet M; Jover R; García-Palomo A; Mauriz JL; González-Gallego J
Br J Cancer; 2013 Jul; 109(1):83-91. PubMed ID: 23756865
[TBL] [Abstract][Full Text] [Related]
18. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
Liu X; Zhang A; Xiang J; Lv Y; Zhang X
Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
[TBL] [Abstract][Full Text] [Related]
19. Osthole attenuates angiogenesis in an orthotopic mouse model of hepatocellular carcinoma via the downregulation of nuclear factor-κB and vascular endothelial growth factor.
Yao F; Zhang L; Jiang G; Liu M; Liang G; Yuan Q
Oncol Lett; 2018 Oct; 16(4):4471-4479. PubMed ID: 30214582
[TBL] [Abstract][Full Text] [Related]
20. Yupingfeng Granule Improves Th2-Biased Immune State in Microenvironment of Hepatocellular Carcinoma through TSLP-DC-OX40L Pathway.
Yao F; Yuan Q; Song X; Zhou L; Liang G; Jiang G; Zhang L
Evid Based Complement Alternat Med; 2020; 2020():1263053. PubMed ID: 32351590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
